Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...
Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...
Singapore- Immunomedics, a biopharmaceutical company in the area of antibody-drug conjugates (ADC), announced a co...
SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been aw...
Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Me...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to commercialize high ...
A recent article in the Annals of Emergency Medicine reported on the diagnostic accuracy of the newly released Beckman C...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, and Antengene Corporation, a biopharmaceutical company, recen...
Puma Biotechnology, Inc., a biopharmaceutical company, and Strata Oncology, Inc., a precision oncology company, have ent...
Eisai Co., Ltd. announces that a total of 13 presentations highlighting results from a Phase II clinical study (Study 20...
About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's...
Northlane Capital Partners has announced that it has made an investment in Firma Clinical Research (“Firma”)...
The Health Sciences Authority has approved Novartis Kisqali (Ribociclib, LEE011), earlier this year as a first-line trea...
Singapore – Scientists from A*STAR’s Institute of Molecular & Cell Biology (IMCB) have discovered a key ...
Singapore – Researchers at A*STAR’s Singapore Bioimaging Consortium (SBIC) have identified a new region of t...
Singapore – Bayer announced results from the Asian analysis of OPTIMIS, the first prospective real-world stud...
Inovio Pharmaceuticals, today announced positive Phase 1 results of its collaborative vaccine study with INO-4700 ...
Singapore- Sorrento Therapeutics announced that it has acquired the Sofusa lymphatic delivery technology platform from K...
